Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. [electronic resource]
Producer: 20001130Description: 1520-8, 2 p following 1528 p. digitalISSN:- 0028-4793
- Adult
- Arthritis, Rheumatoid -- drug therapy
- Cardiovascular Diseases -- mortality
- Cyclooxygenase 2
- Cyclooxygenase 2 Inhibitors
- Cyclooxygenase Inhibitors -- therapeutic use
- Duodenal Obstruction -- chemically induced
- Female
- Gastric Outlet Obstruction -- chemically induced
- Gastrointestinal Diseases -- chemically induced
- Gastrointestinal Hemorrhage -- chemically induced
- Humans
- Isoenzymes -- antagonists & inhibitors
- Lactones -- adverse effects
- Male
- Membrane Proteins
- Middle Aged
- Naproxen -- adverse effects
- Peptic Ulcer -- chemically induced
- Proportional Hazards Models
- Prostaglandin-Endoperoxide Synthases
- Sulfones
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.